COMP <GO>
ASML vs LRCX // EV/EBITDA & P/E VALUATION
ASML Holding N.V. New York Registry Shares (NASDAQ) VS. Lam Research Corporation (NASDAQ) • 15-METRIC TALLY: ASML 6
— LRCX 7
▲ EV/EBITDA & P/E VALUATION LEADER: ASML
LAST: $1,565.90 (-6.55%) • MKT CAP: $645.84B
valuation
14.9x
LAST: $239.11 (-6.01%) • MKT CAP: $317.78B
valuation
34.8x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ASML VS. LRCX)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ASML | LRCX | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 50.50% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 14.90% | 25.50% | -10.60 | LRCX | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 14.9x | 34.8x | -19.90 | ASML | /valuation <GO> |
| Free Cash Flow Yield | 3.99% | 1.51% | +2.48 | ASML | /fcf-yield <GO> |
| Operating Margin | 21.10% | 35.30% | -14.20 | LRCX | /operating-margins <GO> |
| Net Profit Margin | 16.40% | 31.30% | -14.90 | LRCX | /net-margins <GO> |
| Revenue Growth (YoY) | -4.40% | 26.00% | -30.40 | LRCX | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.40% | -0.40 | LRCX | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.87 | 21.80 | -17.93 | LRCX | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 8/9 | -1.00 | LRCX | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 50.0 | 41.7 | +8.30 | ASML | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.31 | 1.29 | +0.02 | ASML | /macro-sensitivity <GO> |
| Forward P/E Multiple | 20.2x | 36.7x | -16.50 | ASML | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $645.84B | $317.78B | $328.07B | ASML | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ASML REV | LRCX REV | ASML GROSS % | LRCX GROSS % | ASML FCF | LRCX FCF |
|---|---|---|---|---|---|---|
| FY 2025 | — | $23.23B | — | 50.5% | — | $4.81B |
| FY 2024 | — | $18.44B | — | 48.7% | — | $5.34B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ASML // BETA 1.31
LRCX // BETA 1.29